Literature DB >> 11927048

The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases.

Charlotte A. Gaydos1, Anne M. Rompalo.   

Abstract

Studies have reported that self-collected specimens, such as urine or vaginal swabs, can be successfully used to diagnose sexually transmitted infections when they are used with nucleic acid amplification assays. This eliminates the necessity for a clinician-performed pelvic examination for women, or a urethral swab for men, for sample collection. These nucleic acid amplification assays used with self-collected specimens are highly sensitive and specific, and their use may be extended to broad nonclinic screening venues, where their use can augment public health programs designed to control the epidemic of sexually transmitted diseases.

Entities:  

Year:  2002        PMID: 11927048     DOI: 10.1007/s11908-002-0057-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  109 in total

1.  Use of nucleic acid amplification tests in investigating child sexual abuse.

Authors:  M R Hammerschlag
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

2.  Chlamydia trachomatis: the more you look, the more you find--how much is there?

Authors:  J Schachter
Journal:  Sex Transm Dis       Date:  1998-05       Impact factor: 2.830

3.  Relative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men.

Authors:  H Cheng; M Macaluso; S H Vermund; E W Hook
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Detection of experimental Chlamydia trachomatis eye infection in conjunctival smears and in tissue culture by use of fluorescein-conjugated monoclonal antibody.

Authors:  H R Taylor; N Agarwala; S L Johnson
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Rapid diagnosis of chlamydial infections with the MicroTrak direct test.

Authors:  C T Uyeda; P Welborn; N Ellison-Birang; K Shunk; B Tsaouse
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

6.  Incident Chlamydia trachomatis infections among inner-city adolescent females.

Authors:  G R Burstein; C A Gaydos; M Diener-West; M R Howell; J M Zenilman; T C Quinn
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

7.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.

Authors:  K R Smith; S Ching; H Lee; Y Ohhashi; H Y Hu; H C Fisher; E W Hook
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens.

Authors:  P C Iwen; R A Walker; K L Warren; D M Kelly; S H Hinrichs; J Linder
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

View more
  14 in total

1.  The available pool of sex partners and risk for a current bacterial sexually transmitted infection.

Authors:  Jacky M Jennings; Ralph Taylor; Vince G Iannacchione; Susan M Rogers; Shang-En Chung; Steven Huettner; Jonathan M Ellen
Journal:  Ann Epidemiol       Date:  2010-07       Impact factor: 3.797

2.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

3.  Gonorrhea Update.

Authors:  Margaret C. Bash
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

4.  Searching for How Best to Accomplish Recommended Rescreening for Genital Chlamydia Infection.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

5.  Testing for sexually transmitted infections: a brave new world?

Authors:  R W Peeling
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

6.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

7.  Neighborhood drug markets: a risk environment for bacterial sexually transmitted infections among urban youth.

Authors:  Jacky M Jennings; Ralph B Taylor; Rama A Salhi; C Debra M Furr-Holden; Jonathan M Ellen
Journal:  Soc Sci Med       Date:  2012-02-13       Impact factor: 4.634

Review 8.  Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Anna S Graseck; Shirley L Shih; Jeffrey F Peipert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-02       Impact factor: 5.091

9.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.